News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

International AIDS Vaccine Initiative, GlycoMimetics, Inc., and Glycosensors and Diagnostics Collaborate to Develop Novel AIDS Vaccine Candidate


5/9/2012 10:31:56 AM

NEW YORK & GAITHERSBURG, Md. & ATHENS, Ga.--(BUSINESS WIRE)--The International AIDS Vaccine Initiative (IAVI), GlycoMimetics, Inc. (GMI), and Glycosensors and Diagnostics, LLC (G&D) today announced a collaboration to develop an AIDS vaccine using novel compounds that mimic carbohydrates, called glycomimetics. The project will be funded by IAVI’s Innovation Fund, a program launched to support the application of novel and unconventional technologies to AIDS vaccine design and development.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES